BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cordier C, Prevarskaya N, Lehen'kyi V. TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer. Cancers (Basel) 2021;13:6322. [PMID: 34944940 DOI: 10.3390/cancers13246322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacology & Therapeutics 2022;240:108302. [DOI: 10.1016/j.pharmthera.2022.108302] [Reference Citation Analysis]
2 Lee J, Bae A, Lee H, Lee J. Clinical and Prognostic Values of TRPM7 in Colon and Rectal Cancers. Medicina 2022;58:1582. [DOI: 10.3390/medicina58111582] [Reference Citation Analysis]
3 Cheng X, Li S, Chen Y, Zhao Y, Hu W, Lu C, Zhou R. Transient receptor potential melastatin 7 and their modulators. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175180] [Reference Citation Analysis]
4 Chen TM, Huang CM, Hsieh MS, Lin CS, Lee WH, Yeh CT, Liu SC. TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma. Aging (Albany NY) 2022;14:5250-70. [PMID: 35771152 DOI: 10.18632/aging.204154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Papavassiliou KA, Gargalionis AN, Papavassiliou AG. Polycystins, mechanotransduction and cancer development. J Cell Mol Med 2022. [PMID: 35366054 DOI: 10.1111/jcmm.17298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]